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Differentiation of bone marrow (BM) cells into astroglia expressing the glial fibrillary acidic protein (GFAP) has been reported in vitro
and after intracerebral or systemic BM transplantation. In contrast, recent data suggest that astrocytic differentiation does not occur
from BM-derived cells in vivo. Using transgenic mice that express the enhanced green fluorescent protein (GFP) under the control of the
human glial fibrillary acidic protein (GFAP) promoter, we investigated the potential of adult murine BM-derived cells to differentiate into
macroglia. In the brains of GFAP–GFP transgenic mice, astrocytes were brightly fluorescent from the expression of GFP. When BM from
these animals was transplanted into lethally irradiated wild-type animals, the transgene was detected in the reconstituted hematopoietic
system, but no GFP expression was found in the nervous system. In contrast, GFAP–GFP neuroectodermal anlage grafted into adult
wild-type striatum gave rise to GFP-expressing astrocytes. Because cerebral ischemia has been suggested to promote the differentiation
of BM-derived cells into astrocytes, BM chimeric mice were subjected to focal cerebral ischemia. No GFP-positive cells were found in the
ischemic or contralateral hemispheres of these brains. Even after direct injection of GFAP–GFP transgenic BM cells into wild-type
striatum, no GFP-expressing astroglia were detected. To test the hypothesis that the in vitro environment might be more permissible for
astroglial differentiation, we cultured BM from mice that constitutively express GFP, BM cells expressing GFP from a retroviral vector,
and BM from GFAP–GFP transgenic mice on astrocytes and on organotypic hippocampal slices. In all experimental paradigms, BM-
derived cells were found to differentiate into ramified microglia but not into GFAP-expressing astrocytes.
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Introduction
Astrocytes are the most numerous glial cells of the CNS and are
thought to derive from multipotent and glial-restricted progeni-
tors, including O-2A progenitors (Mehler and Gokhan, 1999).
Recently, astrocytes have themselves been suggested to act as neu-
ral stem cells, capable of generating macroglia and neurons
(Doetsch et al., 1999; Seri et al., 2001; Heins et al., 2002). More-
over, astrocytes from hippocampus appear to stimulate adult
neurogenesis (Song et al., 2002). Although macroglia, i.e., astro-
cytes and oligodendrocytes, have traditionally been considered
neuroectodermal of origin, recent experiments using radiation
bone marrow (BM) chimeras have suggested that0.5% of CNS
astrocytes may derive from the bone marrow (Eglitis and Mezey,
1997; Eglitis et al., 1999). Marrow stromal cells were found to
differentiate into astrocytes after intraventricular injection into
neonatal mouse brains and after intravenous administration after
cerebral ischemia in rats (Kopen et al., 1999; Chen et al., 2001).
Moreover, intravenous and intrastriatal transplantation of genet-
ically marked BM cells into irradiated mice led to the generation
of some GFAP-expressing astrocytes (Nakano et al., 2001; Corti
et al., 2002a,b). Even more surprisingly, BM-derived cells have
recently been shown to differentiate into cells expressing neuro-
nal antigens in vivo (Brazelton et al., 2000; Mezey et al., 2000;
Priller et al., 2001a). Yet, among 8000 astrocytes counted by Bra-
zelton et al. (2000), not a single cell was derived from the bone
marrow. Neither Nakano et al. (2001) nor Hess et al. (2002) were
able to detect donor-derived astrocytes in radiation bone marrow
chimeras.
Controversy also exists with regard to the in vitro data on the
differentiation of BM stromal cells into astroglia. Although
Sanchez-Ramos et al. (2000), Kohyama et al. (2001), and Jiang et
al. (2002) found that mouse and human marrow stromal/mesen-
chymal cells developed into astrocytes in vitro, Woodbury et al.
(2000) and Deng et al. (2001) could not detect any generation of
astroglia from adult rat and human BM stromal cells.
In this study, we used transgenic mice that express enhanced
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green fluorescent protein (GFP) under the control of the human
GFAP promoter (Nolte et al., 2001) to address the issue of astro-
glial differentiation of BM-derived cells. GFAP is the principal
8 –9 nm intermediate filament protein in mature astrocytes of the
CNS (Eng et al., 2000). The GFAP promoter has been well char-
acterized (for review, see Brenner, 1994). In our GFAP–GFP
transgenic mice, strong expression of the GFP fluorophore was
detected in both protoplasmic and fibrous astrocytes. The level of
GFP expression varied with age and the brain region examined.
Radial glia from the transgenic mice expressed GFP and differen-
tiated into GFAP-positive astrocytes in vitro (M. Go¨tz, unpub-
lished observations). Similar results were obtained in a transgenic
mouse line expressing hGFP-S65T under the human GFAP pro-
moter (Malatesta et al., 2000). When transplanted into irradiated
wild-type mice or injected into the ischemic striatum of wild-type
mice, we did not find GFAP–GFP transgenic BM-derived cells to
differentiate into astrocytes. Moreover, these cells did not acquire
an astroglial phenotype in vitro. Under the same experimental
conditions, BM cells that constitutively express GFP differenti-
ated into ramified microglia.
Materials and Methods
Animals. Transgenic mice expressing GFP under the control of the hu-
man GFAP promoter were generated on FVB/N background (Nolte et al.,
2001). Eight- to 12-week-old wild-type FVB/N and FVB/N  C57BL/6
mice (Charles River, Sulzfeld, Germany) were used as BM recipients in
transplantation studies and for intracerebral grafting. BM obtained from
adult NMRI mice (Charite´ breeding facility, Berlin, Germany) and from
GFAP–GFP transgenic mice crossed into the C57BL/6 strain was used for
retroviral transduction. BM cells were cultured on astrocytes or on hip-
pocampal slices from newborn NMRI mice. Transgenic mice expressing
GFP under the control of the -actin promoter were generated on
C57BL/6 background (Okabe et al., 1997). These mice were generously
provided by Dr. Okabe (Osaka University, Japan). All animal procedures
were performed under the local guidelines for animal use in experimental
laboratory research.
Retroviral transduction of bone marrow cells. BM was harvested from
femurs and tibias 48 hr after treatment with 150 mg/kg 5-fluoruracil
(Sigma, Deisenhofen, Germany). Transduction of BM cells with a mu-
rine stem cell virus-based retroviral vector containing the GFP cDNA was
performed as described in Priller et al. (2001b). Briefly, BM cells were
cultured in DMEM supplemented with 15% fetal calf serum (FCS; Bio-
chrom, Berlin, Germany), 50 ng/ml rat stem cell factor (generously pro-
vided by Amgen, Thousand Oaks, CA), 20 ng/ml interleukin-3, and 50
ng/ml interleukin-6 (Promocell, Heidelberg, Germany). After 2 d, BM
cells were transferred onto irradiated (13 Gy) viral producer cells and
cultured for another 48 hr. Nonadherent BM cells were finally rinsed off
the producer cell monolayer. Efficiency of gene transfer into clonogenic
hematopoietic precursors was assessed in colony assays on methylcellu-
lose supplemented with hematopoietic cytokines (Stem Cell Technolo-
gies, Vancouver, British Columbia, Canada).
Bromodeoxyuridine labeling. BM cells were exposed to 3M bromode-
oxyuridine (BrdU; Sigma) during the above described retroviral trans-
duction procedure. BrdU was supplemented daily for 4 consecutive days.
BrdU-labeled BM cells were washed several times in PBS before culture
on astrocytes.
Generation of GFAP–GFP bone marrow chimeras. BM transplantation
was performed as described previously (Priller et al., 2001b). BM cells
(5 10 6) were resuspended in PBS/2% FCS and injected intravenously
into lethally irradiated (two doses of 5.5 Gy separated by 3 hr) recipient
mice. In one set of experiments, GFAP–GFP BM cells were transduced
with the GFP retroviral vector before transplantation. After transplanta-
tion, animals were kept isolated in ventilated filter cages.
Detection of the transgene in blood cell progeny. Six to eight weeks after
BM transplantation, 150 l of peripheral blood was drawn from the tail
veins of GFAP–GFP bone marrow chimeric mice. Genomic DNA was
isolated using the S.N.A.P. whole-blood DNA isolation kit (Invitrogen,
Groningen, The Netherlands). PCR was performed using the following
primers for the GFP gene: sense (5-GCC GCT ACC CCG ACC AC-3),
antisense (5-TTC ACC TTG ATG CCG TTC TTC T-3). PCR condi-
tions were as follows: 3 min of 94°C, 40 cycles of 94°C for 1 min, 55°C for
1 min, 72°C for 1.5 min, final extension at 72°C for 5 min. PCR products
were separated on a 1% agarose gel and visualized using ethidium bro-
mide. After transplantation of GFAP–GFP BM cells transduced with the
GFP retroviral vector, peripheral blood was drawn from the chimeric
mice and leukocytes were analyzed for GFP expression by FACS (Becton
Dickinson, Heidelberg, Germany).
Induction of focal cerebral ischemia. Transient focal cerebral ischemia
(Hara et al., 1996) was induced in GFAP–GFP bone marrow chimeric
mice 12 weeks after BM transplantation. In a separate set of experiments,
chimeras were used that had received GFAP–GFP transgenic BM cells
transduced with the GFP retroviral vector. During surgery, general anes-
thesia was maintained with 1.0% halothane in 70% N2O/30% O2. Body
temperature was kept at 37–37.5°C using a heating pad. The left middle
cerebral artery was occluded by insertion of a silicone-coated monofila-
ment (Heraeus Kulzer, Hanau, Germany) via the left internal carotid
artery. Onset of ischemia was verified by measuring the regional cerebral
blood flow using laser Doppler flowmetry. After 60 min of ischemia, the
monofilament was withdrawn to reperfuse the brain.
Intracerebral grafting procedures. Wild-type mice were subjected to 60
min of focal cerebral ischemia as described above. After 3 hr, 5 10 5 BM
cells from GFAP–GFP transgenic mice were injected into the left isch-
emic striatum. Precise positioning of the grafts was verified in control
mice injected with yellow-green fluorescent polystyrene microspheres
(Molecular Probes, Leiden, The Netherlands). After surgery, animals
were kept isolated in ventilated filter cages.
Embryos of GFAP–GFP transgenic mice were obtained at day 12.5
after conception and transferred into modified Hank’s medium supple-
mented with 10% FCS, 2% glucose at 4°C. The neuroectodermal anlage
was prepared, homogenized in a volume of 30 l, and grafted into the
caudoputamen of adult wild-type mice as described previously (Isen-
mann et al., 1996). Similarly, 5  10 5 BM cells from GFAP–GFP trans-
genic mice were grafted into the caudoputamen of adult wild-type mice.
Evaluation of donor cell engraftment in the CNS. At given time points,
mice were killed by intraperitoneal injection with chloralhydrate, fol-
lowed by transcardial perfusion with ice-cold PBS for 1–2 min and 4%
paraformaldehyde (PFA) for 15 min. The brains were removed, postfixed
in 4% PFA, and sectioned using a cryotome (20 m) or a vibratome (30
m). Every 10th section was mounted onto glass slides and examined by
conventional fluorescence microscopy (Leica, Heidelberg, Germany) or
by confocal laser scanning microscopy (Zeiss, Jena, Germany). Adjacent
sections were stained with hematoxylin and eosin. Representative vi-
bratome sections were immunostained for GFAP as described below.
Preparation of astroglial cell cultures. Astrocytes were prepared from
newborn mice [postnatal day (P) 1–3] according to the method of Mc-
Carthy and De Vellis (1980). Briefly, animals were decapitated and the
brains were removed. The cortices were mechanically dissociated and
washed in PBS. Each cell suspension obtained from two brains was placed
in a flask and cultured in DMEM/10% FCS. After one to two passages,
adherent cells were removed with 0.5% trypsin and plated in 24-well
culture plates at a density of 40,000 cells per well in the above medium.
Astrocytes were used for coculture experiments when they reached con-
fluency. Astroglial cell cultures were characterized by immunocytochem-
istry for GFAP as described below.
Preparation of organotypic entorhinal– hippocampal slice cultures. Or-
ganotypic entorhinal– hippocampal slice cultures (OEHSCs) were pre-
pared from newborn mice (P9 –12) as described previously (Savaskan et
al., 2000). Briefly, animals were decapitated, and the brains were re-
moved and immediately transferred into ice-cold MEM. Vibratome sec-
tions (300 m) were obtained from the hippocampal region and placed
gently onto 0.4m sterile porous membranes (Millipore, Eschborn, Ger-
many). Brain tissue slices were covered with 1 ml of MEM supplemented
with 25% horse serum and 25% HBSS. The culture medium was changed
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every other day. After 5–7 d, OEHCS were used for coculture
experiments.
Culture of BM cells on astrocytes and OEHCS. BM cells were seeded
either onto astrocytic monolayers at a density of 10,000 cells per well or
onto OEHSCs at a density of 100,000 cells per slice. No additional factors
were added to the culture medium, which was changed every 48 hr. After
1, 3, 6, 12, and 18 d, astrocyte/BM-cocultures were fixed with 4% PFA. At
each time point, cells growing in select wells were enzymatically mobi-
lized and mounted onto gelatin-coated glass slides by cytocentrifugation
at 500 rpm for 10 min (Becton Dickinson). Slice cocultures were fixed
with 4% PFA/0.1% glutaraldehyde and snap frozen after 3, 5, and 8 d.
Sections (14m) were obtained on a cryostat and mounted onto gelatin-
coated glass slides. All samples were examined for GFP expression by
conventional fluorescence microscopy. GFP-expressing cells were char-
acterized immunohistochemically as described below.
Immunohistochemistry. Immunohistochemistry was performed as de-
scribed in Priller et al. (2001b). Cultures or sections were incubated
overnight with primary antibodies against GFAP (Dako, Carpinteria,
CA) or Iba1 (generously provided by Dr. Imai, Tokyo, Japan) at dilutions
of 1:500 and 1:100, respectively. A biotinylated secondary antibody (Vec-
tor, Burlingame, CA) was added at a dilution of 1:200 for 1 hr, followed
by visualization of the staining using streptavidin-conjugated Texas Red
or Cy3 dyes (Vector). For BrdU immunodetection, fixed cultures were
incubated in 2N HCl at 37°C for 1 hr followed by permeabilization with
0.3% Triton X-100 (Sigma) for 30 min. Primary antibodies against BrdU
(Harlan, Borchen, Germany) and GFP (Clontech, Palo Alto, CA) were
added overnight at dilutions of 1:200 and 1:250, respectively. Secondary
antibodies conjugated to Texas Red and Alexa 488 (Molecular Probes)
were used for visualization of BrdU and GFP immunoreactivities; omis-
sion of primary antibodies served as negative control.
Results
An overview of the different experimental conditions is shown in
Figure 1.
GFAP–GFP transgenic mice
In the brains of mice that have been genetically engineered to
express GFP under the control of the human GFAP promoter,
brightly fluorescent stellar cells were detected in the gray and
white matter (Fig. 2A). These cells were identified as astrocytes by
their endogenous expression of GFAP (Figs. 2B,C). Moreover,
electrophysiological recordings of GFP-positive cells in the brain
revealed behavior characteristic of astroglia (Nolte et al., 2001).
Note that not all GFAP-immunoreactive cells expressed detect-
able levels of GFP (Fig. 2C). The percentage of GFP-expressing
astrocytes was 50% in the cortex, 80% in the striatum, and 100%
in the cerebellum at the time of BM harvesting. After 1 year, 40%
of the striatal astrocytes expressed GFP (F. Kirchhoff, unpub-
lished observations). Consistent with the cell-specific expression
of the transgene in astrocytes, no fluorescence from GFP was
detected in BM and peripheral blood cells from GFAP–GFP
transgenic mice.
Generation of GFAP–GFP bone marrow chimeras
Transplantation of GFAP–GFP transgenic BM cells into lethally
irradiated wild-type mice led to the reconstitution of hematopoi-
esis with transgenic peripheral blood cell progeny within 6 weeks
(Fig. 3). The percentage of chimerism amounted to up to 70% in
mice transplanted with GFAP–GFP BM cells transduced with a
GFP retroviral vector (Priller at al., 2001b) (n  2). No abnor-
malities of blood counts or blood cell morphology were observed
after bone marrow transplantation. The brains of the GFAP–GFP
BM chimeric mice (n 8) were analyzed for GFP expression 1–3
months after reconstitution. Every 10th cerebral section was
Figure 1. Overview of the different experimental conditions. A, In vivo experiments. BM
from GFAP–GFP transgenic mice was harvested and transplanted into lethally irradiated adult
wild-type mice. The brains of the recipient mice were analyzed for GFP expression before and
after focal cerebral ischemia. GFAP–GFP BM cells transduced with the GFP retroviral vector were
also transplanted into lethally irradiated adult wild-type mice, and the brains were analyzed for
GFP expression after cerebral ischemia. In addition, BM from GFAP–GFP transgenic mice was
directly injected into the brains of adult wild-type mice that had been subjected to focal cerebral
ischemia. B, In vitro experiments. BM from wild-type NMRI mice was harvested and transduced
with a retroviral vector containing the GFP marker gene. BM from-actin–GFP transgenic mice
was also used. BM cells were cultured on astrocytes or on organotypic entorhinal– hippocampal
slice cultures. GFP-expressing cells were characterized by immunohistochemistry for GFAP and
Iba1. In addition, BM from GFAP–GFP transgenic mice was cultured on astrocytes or on ento-
rhinal– hippocampal slices. The cocultures were analyzed for GFP expression. C, Grafting exper-
iments. Adult BM cells or embryonic neuroectodermal anlage from GFAP–GFP transgenic mice
was grafted into the caudoputamen of adult wild-type mice. The brains were analyzed for GFP
expression.
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carefully evaluated, but not a single GFP-positive cell was de-
tected. In two chimeras, the entire brains were screened for GFP-
expressing cells. No neuropathological changes were observed on
hematoxylin and eosin stains of the brain sections.
Induction of transient focal cerebral
ischemia in GFAP–GFP bone
marrow chimeras
Because cerebral ischemia has been sug-
gested to promote the differentiation of
BM-derived cells into astrocytes in vivo
(Eglitis et al., 1999), GFAP–GFP BM chi-
meras were subjected to focal cerebral
ischemia by occlusion of the middle cere-
bral artery for 60 min (n 6). Reperfusion
times were 1–5 d. As demonstrated by he-
matoxylin and eosin staining, all animals
developed large left-hemispheric infarcts
after middle cerebral artery occlusion
(MCAO) (Fig. 2D). Immunohistochemis-
try for GFAP revealed marked astrogliosis,
demarcating the border of the ischemic
core (Fig. 2E). No GFP-expressing cells
were detected in ipsilateral (Fig. 2F) and
contralateral sections of the ischemic
brains when every 10th section was scored.
To demonstrate the presence of BM-
derived cells in the ischemic brain, GFAP–
GFP transgenic BM cells were transduced
with GFP using a murine stem cell virus-
based retroviral vector before transplanta-
tion into lethally irradiated adult wild-type
mice. Four weeks after BM transplantation,
the chimeras were subjected to 60 min of
MCAO and 5–14 d of reperfusion (n 2). A
large infiltrate of GFP-expressing cells was
detected in the ischemic hemisphere (Fig.
2G), indicating that donor-derived cells
engraft and survive in the lesioned brain.
Ramified GFP-expressing cells were immu-
noreactive for Iba1 (Figs. 2H,I), suggesting
that BM-derived cells differentiated into mi-
croglia (Imai et al., 1996).
Intracerebral grafts of GFAP–GFP transgenic cells
On the basis of previous results reported by Kopen et al. (1999)
and Nakano et al. (2001), we presumed that blood cells might
differentiate more easily into brain cells from intracerebral grafts
of bone marrow. Thus, GFAP–GFP BM cells were injected into
the ischemic striatum of wild-type mice 3 hr after MCAO (n 4).
The correct positioning of the grafts was confirmed by hematox-
ylin and eosin staining visualizing the needle tract. No GFP-
expressing astrocytes were detected in the striatal grafts up to 7 d
after transplantation. When GFAP–GFP BM cells were grafted
into the caudoputamen of wild-type mice (n  4), an astroglial
scar was detected around the injection site at 6 weeks after graft-
ing, but none of the cells were expressing GFP (Figs. 4A–C). In
contrast, E12.5 neuroectodermal tissue from GFAP–GFP trans-
genic mice was GFP negative at the time of grafting into the
caudoputamen of wild-type mice (n 4) but gave rise to numer-
ous GFP-expressing astrocytes within 6 weeks (Figs. 4D–F).
Thus, the adult murine brain retains the potential to induce an
astroglial fate in transplanted stem/progenitor cells.
Differentiation of bone marrow-derived cells into microglia
on astrocyte cultures
To evaluate the potential of BM cells to differentiate into neuro-
glia in vitro, we transferred the GFP gene into BM cells using the
Figure 2. Characterization of transgenic mice that express GFP under the control of the GFAP-promoter (GFAP–GFP mice). A,
Striatal brain slices were prepared from 3-month-old GFAP–GFP transgenic mice and analyzed by confocal laser scanning micros-
copy. GFP was expressed in the cytoplasm of protoplasmic astrocytes. B, Astrocytes expressed the intermediate filament protein,
GFAP, as revealed by immunohistochemistry using Cy3-conjugated secondary antibodies. C, Overlay of images A and B demon-
strates coexpression but differential subcellular localization of the two proteins. The majority of astrocytes expressed detectable
amounts of GFP. The images display projections of 230 130 13m. D–F, Induction of focal cerebral ischemia in GFAP–GFP
BM chimeras. Representative hematoxylin and eosin-stained section of a mouse brain 48 hr after MCAO (60 min). The ischemic
lesion is visible on the right ( D). E, F, Immunohistochemical analysis of GFAP expression. Marked astrogliosis ( E) demarcated the
border of the ischemic lesion 48 hr after MCAO in a GFAP–GFP BM chimera. No GFP expression could be detected in the same visual
field ( F), indicating that GFAP expression did not occur in BM-derived cells. G–I, Five days after MCAO (60 min) in a BM chimera
that had received GFAP–GFP transgenic BM cells labeled with GFP using a retroviral vector, donor-derived cells were detectable in
the ischemic hemisphere by virtue of their GFP expression ( G). Immunohistochemistry for Iba1 revealed marked activation of
microglia and macrophages in the lesioned tissue ( H ). Some BM-derived cells have differentiated into microglia, as indicated by
their ramified morphology and coexpression of GFP and Iba1 ( I ). Scale bars: A–F, 50m; G–I, 10m.
Figure 3. Presence of the transgene in peripheral blood cells from GFAP–GFP bone marrow
chimeras. Genomic DNA from peripheral blood leukocytes was analyzed for the presence of the
GFP transgene by PCR. PCR products were separated on an agarose gel and stained with
ethidium bromide. The migration patterns of molecular weight markers are shown on the left.
Lane 1, Negative control (H2O); lanes 2– 6, GFAP–GFP BM chimeric mice. Note that the animal
from lane 2 has not been successfully reconstituted with GFAP–GFP BM, whereas the chimeras
from lanes 3– 6 carry transgenic blood cell progeny.
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above mentioned retroviral vector. Effi-
ciency of gene transfer into myeloid clono-
genic progenitors was assessed to be
90%. The fluorescence from GFP in BM
cells was intense and stable over3 weeks
in culture. GFP-expressing BM cells were
cultured on astroglial monolayers (n  4
with five time points each and four wells
per time point). In a parallel study, prela-
beling of GFP-expressing BM cells with
BrdU was performed to account for BM
cells that failed to express GFP (n 2 with
three time points each and two to six wells
per time point). BM cells were significantly
smaller than the underlying astrocytes on
day 1 of the coculture. During the first days
of coculture, 10 –20% of GFP-expressing
cells started to ramify and by day 6 ac-
quired the morphology of “resting” mi-
croglia (Fig. 5A). The number and mor-
phology of ramified GFP-positive cells did
not change between days 7 and 21 of co-
culture. No ramification of GFP-
expressing cells was observed when BM
cells were cultured on polycarbonate
dishes in the absence of astrocytes. The ramified GFP-expressing
cells were identified as microglia by their immunoreactivity for
the Iba1 antigen (Figs. 5C,E), an intracellular epitope expressed
by monocytes, macrophages, and microglia (Imai et al., 1996).
Not a single GFP-positive cell was found to express GFAP after up
to 21 d of coculture (Figs. 5B,D,F). To exclude any misleading
overlay of the GFP and GFAP signals in astrocyte cultures, cells
from select wells were enzymatically dissociated and analyzed for
GFP and GFAP expression on a single cell level. Thus, 1500 cells
were evaluated, but no GFP-positive cell was found to express
GFAP. The number of BrdU-labeled cells in the coculture re-
mained fairly constant between 6 and 18 d in vitro, and most of
the GFP-expressing cells were immunoreactive for BrdU (Figs.
5G–I). The ratio of BrdU- versus GFP-positive cells was2:1.
When bone marrow from transgenic mice that constitutively
express GFP under the control of the-actin promoter (Okabe et
al., 1997) was cultured on astrocytes, differentiation of BM-
derived cells into Iba1-positive microglia, but not into GFAP-
expressing astrocytes, was observed (n 1 with five time points
and four wells per time point). Moreover, when BrdU-labeled
BM from transgenic mice that express GFP under the control of
the GFAP promoter was cultured on astrocytes, no GFP expres-
sion was detected in the cocultures after up to 18 d, and BM-
derived cells were identified by their immunoreactivity for BrdU
(n 2 with four time points and two wells per time point). These
findings in two independent transgenic models confirm the
above results obtained with BM cells transduced with a retroviral
vector.
Differentiation of bone marrow-derived cells into microglia
on OEHSCs
To take advantage of an organotypic microenvironment, GFP-
transduced BM cells were seeded on top of entorhinal– hip-
pocampal slice cultures (n  3 with three time points each and
four to six slices per time point). Duration of coculture experi-
ments was limited to 8 d because of the progressive astrogliosis of
the brain slices. Using fluorescence microscopy of living and fixed
slice cultures, GFP-expressing cells were found to migrate from
the top into the deeper layers of the tissue. As early as 3 d after
inoculation, ramified GFP-expressing cells were detected in var-
ious depths of the slice cultures (Fig. 5J). These cells stained
positive for the Iba1 antigen, indicating their microglial identity
(Figs. 5K,L). At no time point were GFAP-expressing astrocytes
of bone marrow origin detected.
When BM from transgenic mice that constitutively express
GFP under the control of the -actin promoter was cultured on
OEHSCs, differentiation of BM-derived cells into Iba1-positive
microglia, but not into GFAP-expressing astrocytes, was ob-
served (n  1 with three time points and four slices per time
point). Moreover, when BM from transgenic mice that express
GFP under the control of the GFAP promoter was cultured on
OEHSCs, no GFP expression was detected in the cocultures after
up to 8 d (n  1 with three time points and four slices per time
point). These findings in two independent transgenic models
confirm the above results obtained with BM cells transduced with
a retroviral vector.
Discussion
Our results add to the controversy regarding the origin of astro-
cytes in the adult rodent brain. Brazelton et al. (2000) recently
suggested that microglia/macrophages and neuron-like cells but
not astrocytes were generated from the bone marrow that recon-
stituted hematopoiesis in lethally irradiated adult mice. As in our
protocol, the green fluorescent protein was used to mark BM-
derived cells. Similarly, Nakano et al. (2001) failed to detect any
donor-derived astrocytes in chimeras transplanted with BM cells
expressing GFP under the control of the -actin promoter. In
contrast, Corti et al. (2002a,b) found some GFAP-expressing as-
trocytes in -actin–GFP bone marrow chimeras. Recently, trans-
plantation of multipotent adult progenitor cells, which can dif-
ferentiate into all neuroectodermal lineages in vitro and after
injection into an early blastocyst, did not result in engraftment of
donor-derived astrocytes in the adult brain (Jiang et al., 2002). In
contrast, Eglitis and Mezey (1997) reported that 0.5–2% of the BM-
derived cells that had engrafted in the CNS after transplantation of
male BM cells into lethally irradiated female WBB6F1/J-Kitw/J-
Figure 4. Differentiation of GFAP–GFP transgenic neuroectodermal anlage, but not of bone marrow cells, into GFAP-
expressing astrocytes after intracerebral grafting. A–C, GFAP–GFP BM cells were grafted into the caudoputamen of wild-type
mice. In a representative section, the needle tract was visualized on hematoxylin and eosin staining ( A). The injection site was
demarcated by reactive astrocytes that stained for GFAP ( C) but did not express GFP ( B) 6 weeks after grafting. D–F, Neuroecto-
dermal anlage from embryos of GFAP–GFP transgenic mice was grafted into the caudoputamen of wild-type mice. The graft could
be readily identified on a representative hematoxylin and eosin-stained section ( D) and contained numerous GFAP-
immunoreactive astrocytes ( F) that also expressed GFP ( E). Scale bars, 50m.
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KitW-v mice expressed GFAP. It should be noted that the recipient
mouse strain used in their study was genetically defective in stem
cells. Moreover, characterization of engrafted BM cells required in
situ hybridization histochemistry for the Y chromosome combined
with immunohistochemistry for GFAP. Using GFP as a reporter
driven by the GFAP promoter, we avoided challenging double-
labeling studies. Moreover, we excluded the possibility that antibod-
ies may recognize a GFAP-like epitope rather than astrocytic GFAP.
On the other hand, the human promoter driving transgene expres-
sion in our mice may not replicate exactly the regulatory properties
of the endogenous GFAP promoter and appears to be susceptible to
gene silencing in vivo. To exclude the possibility that GFP expression
was simply below the limit of detection, or that some astrocytes even
failed to activate the transgenic promoter, GFAP–GFP transgenic
BM cells were transduced with a GFP retroviral vector before trans-
plantation. In accordance with previously published data using
GFP-expressing bone marrow (Nakano et al., 2001; Priller et al.,
2001b), the donor-derived cells acquired a microglial phenotype
in the CNS. Although specific BM stem cell populations giving
rise to astroglia may have been selected against in vitro in these
experiments, it should be noted that the stem cells generating
astroglia in the study of Eglitis and Mezey (1997) had also under-
gone retroviral transduction before transplantation.
Cramer and Chopp (2000) recently suggested that recovery
from cerebral ischemia recapitulates ontogeny. The microenvi-
ronment of the ischemic brain therefore may promote the differ-
entiation of BM-derived cells into astrocytes. As a matter of fact,
Eglitis et al. (1999) found that 4 –5% of the Y chromosome-
positive, BM-derived cells that had engrafted in the ischemic
brains of chimeric hypertensive rats within 48 hr were also GFAP
positive. Chen et al. (2001) reported that 5% of bromode-
oxyuridine-labeled BM stromal cells infused into ischemic rats
expressed GFAP. In the present study, no GFAP–GFP BM-
derived cells were found to differentiate into astrocytes in the
ischemic mouse brain. Hess et al. (2002) also failed to detect
donor-derived astrocytes in GFP bone marrow chimeras after
MCAO. We confirmed engraftment of transgenic BM cells in the
lesioned brain by retroviral GFP labeling of the bone marrow
before transplantation. The engrafted GFP-expressing cells were
identified as microglia/macrophages. It should be noted, how-
ever, that the duration of MCAO in our study was substantially
shorter than in the previous experiments of Eglitis et al. (1999)
and Chen et al. (2001), and we used a different species.
Immunodepleted marrow stromal cells labeled with bro-
modeoxyuridine after 7 d in culture and injected into the ventri-
cle of newborn (P3) mice were reported to migrate throughout
the forebrain and cerebellum and to differentiate into GFAP-
expressing astrocytes (Kopen et al., 1999). GFP-expressing BM
cells injected into the striatum of an irradiated adult mouse were
found to differentiate into astrocytes, oligodendrocytes, and mi-
croglia, but none turned into neurons (Nakano et al., 2001). Zhao
et al. (2002) recently detected macroglia and neuronal pheno-
types derived from human BM stem cells grafted into the isch-
emic brains of spontaneously hypertensive rats. However, Hof-
stetter et al. (2002) found that marrow stromal cells transplanted
into the injured spinal cord promoted recovery but failed to dif-
ferentiate into GFAP-expressing astrocytes. When we grafted
GFAP–GFP transgenic BM cells into the striatum of adult wild-
type mice, no differentiation of BM cells into GFP-expressing
astrocytes was observed. In contrast, embryonic neuroectoder-
mal tissue from GFAP–GFP transgenic mice gave rise to GFP-
positive astrocytes when grafted into adult wild-type mice. This is
an important control because it demonstrates that the transgene
can be expressed in cells transplanted into the adult brain. More-
over, the microenvironment of the adult brain apparently allows
for astroglial differentiation of grafted cells. It is conceivable that
slight variations in protocol, such as differences in age and con-
dition of the recipient animals, injection site, and selection of
specific BM stem cell populations before transplantation may
account for the discrepancies observed between this and previous
Figure 5. Differentiation of GFP-transduced bone marrow cells into microglia on cultured
astrocytes and on OEHSCs. A–I, Retroviral transfer of the GFP gene into wild-type BM cells was
followed by culture of these cells on astroglial monolayers. After 6 d of coculture, GFP-
expressing BM-derived cells were highly ramified (A, B). Immunohistochemical analysis re-
vealed that all ramified GFP-expressing cells ( A) were Iba1 positive ( C). Images in A and C are
superimposed in E. No colocalization of the GFP signal ( B) with GFAP ( D) is observed. Images in
B and D are superimposed in F. Note that the GFAP immunoreactivity in D results from the
astrocytic monolayer on which BM cells were cultured. Six days after culture on astroglia of
BrdU-labeled BM cells transduced with the GFP retroviral vector, GFP-expressing cells ( G)
showed nuclear BrdU immunoreactivity ( H ). Images in G and H are superimposed in I. Note that
the degree of BrdU immunoreactivity varied and that GFP gene transfer was incomplete, indi-
cated by the presence of numerous BrdUGFP cells. J–L, Retroviral transfer of the GFP gene
into wild-type BM cells was followed by culture of these cells on OEHSCs. After 8 d of coculture,
many GFP-expressing BM-derived cells were ramified ( J). Immunohistochemical analysis re-
vealed that the ramified GFP-expressing cells were Iba1 positive ( K). Colocalization is demon-
strated in the overlay ( L). Not all Iba1-expressing cells were GFP positive, because most of the
microglia and macrophages in the coculture were derived from the original slice tissue. Scale
bars: A, C, E, 10m; B, D, F, 20m; G, H, I, 5m; J, K, L, 10m.
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studies. In fact, our approach is different from the above men-
tioned studies in that BM cells were injected directly into the
brain without in vitro treatment, which may have induced
predifferentiation.
The GFP molecule has been expressed in a wide variety of
cultured cells without deleterious effects (Cheng et al., 1996). In a
transgenic model, GFP was placed under the control of an oligo-
dendroglial promoter, and the differentiation of glial cells was
not affected (Fuss et al., 2000). The GFAP–GFP transgenic mice
used in this study express GFP from birth to adulthood (Nolte et
al., 2001; present study). Neurografts from the transgenic mice
give rise to GFP GFAP astrocytes (present study). Neither
astroglial morphology nor function is altered in the transgenic
mice. Mice transplanted with GFAP–GFP BM cells engrafted
with normal kinetics, as indicated by the presence of the trans-
gene in peripheral blood leukocytes 8 weeks after transplantation.
The fact that GFP expression does not interfere with the differ-
entiation of BM-derived cells into glia is underscored by the gen-
eration of Iba1-positive microglia from GFP-marked bone mar-
row. GFP-expressing BM cells cultured on astrocytes or on
hippocampal slice cultures were found to adopt the morphology
of ramified microglia within 1 week of coculture. These results
extend previous findings suggesting that blood monocytes and
spleen macrophages ramify and show the properties of microglia
when cultured on astrocytes for 8 –14 d (Sievers et al., 1994). As in
our study, the absence of astroglia prevented the ramification of
blood-borne cells, suggesting that diffusible factors do not suffice
for microglial differentiation of BM-derived cells.
No GFAP-expressing cells of bone marrow origin were de-
tected when either GFP-transduced BM cells, BM cells that con-
stitutively express GFP, or GFAP–GFP transgenic BM cells were
cultured on astrocytes or on hippocampal slice cultures. These
results are in line with the observations of Woodbury et al. (2000)
and Deng et al. (2001), who reported that adult rat and human
bone marrow stromal cells differentiate into neurons but not into
GFAP-expressing astrocytes in vitro. In contrast, Sanchez-Ramos
et al. (2000), Kohyama et al. (2001), and Jiang et al. (2002) re-
cently suggested that adult bone marrow cells have the capacity to
differentiate into macroglia in vitro. Specific culture conditions and
treatment of stromal cells with growth factors and a demethylating
agent or neurogenic factor, such as Noggin, may have been instru-
mental in generating macroglia from mesenchymal stem cells.
In conclusion, these data suggest that the generation of CNS
astroglia from bone marrow in the adult mouse may not be as
robust as reported previously. Additional experiments are re-
quired to determine the conditions under which bone marrow
stem cells may switch lineage and give rise to GFAP-expressing
astrocytes.
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